South & Central America Organoids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. South & Central America Organoids Market – Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Demand for Tumor Modeling and Biobanking

4.1.2 Surging Adoption of Personalized Drugs

4.2 Market Restraints

4.2.1 Dearth of Skilled Professionals

4.3 Market Opportunities

4.3.1 Focus on Drug Discovery Activities

4.4 Future Trends

4.4.1 Combination of Organoids and Organ-on-a-Chip

4.5 Impact of Drivers and Restraints:

5. Organoids Market – South & Central America Analysis

5.1 South & Central America Organoids Market Revenue (US$ Million), 2021–2031

5.2 South & Central America Organoids Market Forecast Analysis

6. South & Central America Organoids Market Analysis – by Type

6.1 Intestine

6.1.1 Overview

6.1.2 Intestine: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.2 Liver

6.2.1 Overview

6.2.2 Liver: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.3 Stomach

6.3.1 Overview

6.3.2 Stomach: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.4 Pancreas

6.4.1 Overview

6.4.2 Pancreas: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.5 Lung

6.5.1 Overview

6.5.2 Lung: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.6 Brain

6.6.1 Overview

6.6.2 Brain: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.7 Kidney

6.7.1 Overview

6.7.2 Kidney: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.8 Others

6.8.1 Overview

6.8.2 Others: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7. South & Central America Organoids Market Analysis – by Application

7.1 Developmental Biology Disease

7.1.1 Overview

7.1.2 Developmental Biology Disease: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2 Pathology of Infectious Disease

7.2.1 Overview

7.2.2 Pathology of Infectious Disease: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.3 Regenerative Medicine

7.3.1 Overview

7.3.2 Regenerative Medicine: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.4 Drug Toxicity and Efficacy Testing

7.4.1 Overview

7.4.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.5 Drug Discovery and Personalized Medicine

7.5.1 Overview

7.5.2 Drug Discovery and Personalized Medicine: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

8. South & Central America Organoids Market Analysis – by Source

8.1 Pluripotent Stem Cells

8.1.1 Overview

8.1.2 Pluripotent Stem Cells: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2 Organ-Specific Adult Stem Cell

8.2.1 Overview

8.2.2 Organ-Specific Adult Stem Cell: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9. South & Central America Organoids Market Analysis – by Offering

9.1 Instruments

9.1.1 Overview

9.1.2 Instruments: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2 Consumables

9.2.1 Overview

9.2.2 Consumables: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3 Services

9.3.1 Overview

9.3.2 Services: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10. South & Central America Organoids Market Analysis – by Method

10.1 Micropatterned Plates

10.1.1 Overview

10.1.2 Micropatterned Plates: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.2 Ultralow Attachment Plates

10.2.1 Overview

10.2.2 Ultralow Attachment Plates: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3 Hanging Drop

10.3.1 Overview

10.3.2 Hanging Drop: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4 Microdroplet or Emulsion

10.4.1 Overview

10.4.2 Microdroplet or Emulsion: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11. South & Central America Organoids Market – Country Analysis

11.1 South & Central America

11.1.1 South & Central America Organoids Market – Revenue and Forecast Analysis – by Country

11.1.1.1 South & Central America Organoids Market – Revenue and Forecast Analysis – by Country

11.1.1.2 Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.2.1 Brazil: South & Central America Organoids Market Share – by Type

11.1.1.2.2 Brazil: South & Central America Organoids Market Share – by Application

11.1.1.2.3 Brazil: South & Central America Organoids Market Share – by Source

11.1.1.2.4 Brazil: South & Central America Organoids Market Share – by Offering

11.1.1.2.5 Brazil: South & Central America Organoids Market Share – by Instruments

11.1.1.2.6 Brazil: South & Central America Organoids Market Share – by Consumables

11.1.1.2.7 Brazil: South & Central America Organoids Market Share – by Method

11.1.1.3 Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.3.1 Argentina: South & Central America Organoids Market Share – by Type

11.1.1.3.2 Argentina: South & Central America Organoids Market Share – by Application

11.1.1.3.3 Argentina: South & Central America Organoids Market Share – by Source

11.1.1.3.4 Argentina: South & Central America Organoids Market Share – by Offering

11.1.1.3.5 Argentina: South & Central America Organoids Market Share – by Instruments

11.1.1.3.6 Argentina: South & Central America Organoids Market Share – by Consumables

11.1.1.3.7 Argentina: South & Central America Organoids Market Share – by Method

11.1.1.4 Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.4.1 Rest of South & Central America: South & Central America Organoids Market Share – by Type

11.1.1.4.2 Rest of South & Central America: South & Central America Organoids Market Share – by Application

11.1.1.4.3 Rest of South & Central America: South & Central America Organoids Market Share – by Source

11.1.1.4.4 Rest of South & Central America: South & Central America Organoids Market Share – by Offering

11.1.1.4.5 Rest of South & Central America: South & Central America Organoids Market Share – by Instruments

11.1.1.4.6 Rest of South & Central America: South & Central America Organoids Market Share – by Consumables

11.1.1.4.7 Rest of South & Central America: South & Central America Organoids Market Share – by Method

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in Organoids Market

12.3 Organic Growth Strategies

12.3.1 Overview

12.4 Inorganic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 STEMCELL Technologies Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Molecular Devices, LLC.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Hubrecht Organoid Technology

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Definigen

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Organoid Therapeutics

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Thermo Fisher Scientific Inc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Corning Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Merck KGaA

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 InSphero

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 ACRO Biosystems.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Bio-Techne Corp

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 SUN bioscience SA

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

13.13 ORGANOID SCIENCES Co., Ltd.

13.13.1 Key Facts

13.13.2 Business Description

13.13.3 Products and Services

13.13.4 Financial Overview

13.13.5 SWOT Analysis

13.13.6 Key Developments

13.14 Crown Bioscience Inc

13.14.1 Key Facts

13.14.2 Business Description

13.14.3 Products and Services

13.14.4 Financial Overview

13.14.5 SWOT Analysis

13.14.6 Key Developments

13.15 Sartorius AG

13.15.1 Key Facts

13.15.2 Business Description

13.15.3 Products and Services

13.15.4 Financial Overview

13.15.5 SWOT Analysis

13.15.6 Key Developments

13.16 3D Biotek LLC

13.16.1 Key Facts

13.16.2 Business Description

13.16.3 Products and Services

13.16.4 Financial Overview

13.16.5 SWOT Analysis

13.16.6 Key Developments

13.17 Prellis Biologics Inc.

13.17.1 Key Facts

13.17.2 Business Description

13.17.3 Products and Services

13.17.4 Financial Overview

13.17.5 SWOT Analysis

13.17.6 Key Developments

13.18 3Dnamics Inc.

13.18.1 Key Facts

13.18.2 Business Description

13.18.3 Products and Services

13.18.4 Financial Overview

13.18.5 SWOT Analysis

13.18.6 Key Developments

13.19 Cellesce Ltd

13.19.1 Key Facts

13.19.2 Business Description

13.19.3 Products and Services

13.19.4 Financial Overview

13.19.5 SWOT Analysis

13.19.6 Key Developments

14. Appendix

14.1 About The Insight Partners

List of Tables

Table 1. South & Central America Organoids Market Segmentation

Table 2. South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3. South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Type

Table 4. South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application

Table 5. South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Source

Table 6. South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Offering

Table 7. South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Method

Table 8. South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 9. Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 10. Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 11. Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 12. Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 13. Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 14. Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 15. Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 16. Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 17. Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 18. Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 19. Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 20. Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 21. Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 22. Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 23. Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 24. Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 25. Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 26. Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 27. Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 28. Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 29. Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 30. Recent Organic Growth Strategies in Organoids Market

Table 31. Recent Inorganic Growth Strategies in the Organoids Market

List of Figures

Figure 1. South & Central America Organoids Market Segmentation – Country

Figure 2. South & Central America Organoids Market – Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. South & Central America Organoids Market Revenue (US$ Million), 2021–2031

Figure 5. South & Central America Organoids Market Share (%) – by Type (2023 and 2031)

Figure 6. Intestine: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 7. Liver: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8. Stomach: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 9. Pancreas: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 10. Lung: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11. Brain: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12. Kidney: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13. Others: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 14. South & Central America Organoids Market Share (%) – by Application (2023 and 2031)

Figure 15. Developmental Biology Disease: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16. Pathology of Infectious Disease: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17. Regenerative Medicine: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18. Drug Toxicity and Efficacy Testing: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 19. Drug Discovery and Personalized Medicine: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 20. Others: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 21. South & Central America Organoids Market Share (%) – by Source (2023 and 2031)

Figure 22. Pluripotent Stem Cells: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 23. Organ-Specific Adult Stem Cell: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 24. South & Central America Organoids Market Share (%) – by Offering (2023 and 2031)

Figure 25. Instruments: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 26. Consumables: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 27. Services: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 28. South & Central America Organoids Market Share (%) – by Method (2023 and 2031)

Figure 29. Micropatterned Plates: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 30. Ultralow Attachment Plates: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 31. Hanging Drop: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 32. Microdroplet or Emulsion: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 33. Others: South & Central America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 34. South & Central America Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 35. Brazil: South & Central America Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 36. Argentina: South & Central America Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 37. Rest of South & Central America: South & Central America Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 38. Growth Strategies in Organoids Market